Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study

about

Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study

Item

http://www.wikidata.org/entity/Q58755495

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 10 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Comparing simultaneous integra ...... rospective observational study

@en

Comparing simultaneous integra ...... rospective observational study

@nl

type

Item

label

Comparing simultaneous integra ...... rospective observational study

@en

Comparing simultaneous integra ...... rospective observational study

@nl

prefLabel

Comparing simultaneous integra ...... rospective observational study

@en

Comparing simultaneous integra ...... rospective observational study

@nl

P1476

Comparing simultaneous integra ...... rospective observational study

@en

P2093

Alessandro Passardi

http://www.w3.org/2001/XMLSchema#string

Alexis Lepinoy

http://www.w3.org/2001/XMLSchema#string

Andrea Evangelista

http://www.w3.org/2001/XMLSchema#string

Berardino De Bari

http://www.w3.org/2001/XMLSchema#string

Elisabetta Trino

http://www.w3.org/2001/XMLSchema#string

Francesca Arcadipane

http://www.w3.org/2001/XMLSchema#string

Gilles Créhange

http://www.w3.org/2001/XMLSchema#string

Giuseppe Carlo Iorio

http://www.w3.org/2001/XMLSchema#string

Martina Valgiusti

http://www.w3.org/2001/XMLSchema#string

Paola Cassoni

http://www.w3.org/2001/XMLSchema#string

P2860

Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.

Volumetric modulated arc therapy (VMAT) in the combined modality treatment of anal cancer patients

Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer.

Early-stage Node-negative (T1-T2N0) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.

Locally Advanced (T3-T4 or N+) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.

RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal

Repopulation of cancer cells during therapy: an important cause of treatment failure.

Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08.

P2888

s13014-018-1124-9

P304

172

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13014-018-1124-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pierfrancesco Franco

Andrea Casadei Gardini

Manuela Ceccarelli

Gabriella Furfaro

Massimiliano Mistrangelo

P577

2018-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106905239

http://www.w3.org/2001/XMLSchema#string

P698

30201015

http://www.w3.org/2001/XMLSchema#string

P932

6131808

http://www.w3.org/2001/XMLSchema#string